Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy - Takeaways - MDSpire

Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy

  • By

  • J. P. Huskin

  • B. Vandekerckhove

  • P. Delincé

  • R. Verdonk

  • J.-E. Dubuc

  • S. Willems

  • P. Hardy

  • F. J. Blanco

  • O. Charrois

  • F. Handelberg

  • June 7, 2008

  • 0 min

Share

  • 1

    Osteoarthritis is a common chronic condition causing joint pain and functional loss, with various treatment options available.

  • 2

    Hylan G-F 20 is a viscosupplement used for knee osteoarthritis, supported by clinical trials for its safety and efficacy.

  • 3

    The study evaluated hylan G-F 20 in patients with knee osteoarthritis who experienced persistent pain after arthroscopic meniscectomy.

  • 4

    Eligible patients had osteoarthritic knee pain 4-12 weeks post-meniscectomy and required specific radiological evidence of OA.

  • 5

    The study was a prospective, multi-centre trial conducted across Europe, focusing on the effectiveness of hylan G-F 20 injections.

Original Source(s)

Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy

  • by J. P. Huskin, B. Vandekerckhove, P. Delincé, R. Verdonk, J.-E. Dubuc, S. Willems, P. Hardy, F. J. Blanco, O. Charrois, F. Handelberg

  • June 7, 2008

Related Content

Integrative multi-omics identifies MSR1 as a programmed cell death and extracellular matrix hub gene in osteoarthritis with hesperidin targeting potential

Shoulder MRI: Rethinking Findings

Routine imaging may detect age-related tendon changes that do not explain patient-reported shoulder pain.

Sleep Disruption and Osteoarthritis Risk

Investigators find that short sleep, insomnia, and night shift work are associated with increased risk of knee and hip osteoarthritis and joint replacement.